Clinical Trials
- Heart/Cardiovascular
Ertugliflozin in Acute Heart Failure
- Ages18 years and older
- GenderBoth
- Cancer
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (HEART)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Mechanisms of Diuretic Resistance in Heart Failure (MsDR)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy (MAPLE)
- Ages18 years - 85 years
- GenderBoth
- Cancer
Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis
- Heart/Cardiovascular, Endocrine System
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations (SCAN-MP)
- Ages60 years and older
- GenderBoth
- Heart/Cardiovascular
Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (ACACIA)
- Heart/Cardiovascular
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)
- Ages8 years and older
- GenderBoth
- Pregnancy and Obstetrics, Heart/Cardiovascular
Chronic Hypertension and Pregnancy (CHAP) Project (CHAP)
- Ages12 years and older
- GenderFemale only
- Heart/Cardiovascular
Multimodal Outcome CHAracterization (MOCHA) in comatose cardiac arrest patients
- Ages18 years and older
- GenderBoth